These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 37848996)
1. The effect of PD-1/PD-L1 signaling axis on the interaction between CD19 Xie Z; Dai L; He H; Hong D; Tang H; Xu W; Chen Z; Wang H; Li B; Xie C; Wang Y Adv Rheumatol; 2023 Oct; 63(1):51. PubMed ID: 37848996 [TBL] [Abstract][Full Text] [Related]
2. The role and clinical significance of programmed cell death- ligand 1 expressed on CD19 Jia XY; Zhu QQ; Wang YY; Lu Y; Li ZJ; Li BQ; Tang J; Wang HT; Song CW; Xie CH; Chen LJ Clin Immunol; 2019 Jan; 198():89-99. PubMed ID: 30502542 [TBL] [Abstract][Full Text] [Related]
3. [The proportion of CD19 Xie Z; Dai L; He H; Hong D; Wang Y; Xu W; Chen Z; Li B; Xie C Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Feb; 40(2):148-157. PubMed ID: 38284256 [TBL] [Abstract][Full Text] [Related]
4. Low expressions of PD-L1 and CTLA-4 by induced CD4 Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334 [TBL] [Abstract][Full Text] [Related]
5. The blockade of PD-1/PD-L1 pathway promotes the apoptosis of CD19 Wang Z; Tan F Scand J Immunol; 2020 Feb; 91(2):e12836. PubMed ID: 31598989 [TBL] [Abstract][Full Text] [Related]
6. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis. Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649 [TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus. Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926 [TBL] [Abstract][Full Text] [Related]
8. Patients with systemic lupus erythematosus show increased proportions of CD19 Zhu Q; Li Y; Zhang L; Wang M; Chen Z; Shi J; Li J; Li B; Li Z; Wang Y; Xie C Clin Rheumatol; 2021 Jan; 40(1):151-165. PubMed ID: 32542581 [TBL] [Abstract][Full Text] [Related]
9. BAFFR expression in circulating T follicular helper (CD4 Sagrero-Fabela N; Ortíz-Lazareno PC; Salazar-Camarena DC; Cruz A; Cerpa-Cruz S; Muñoz-Valle JF; Marín-Rosales M; Alvarez-Gómez JA; Palafox-Sánchez CA Lupus; 2023 Aug; 32(9):1093-1104. PubMed ID: 37460408 [TBL] [Abstract][Full Text] [Related]
10. PD-1/PD-L1 governed cross-talk of exhausted CD8 Wang K; Zhao J; Feng X; He S; Li J; Sun F; Xu Z; Yang H; Ye J; Cao L; Ye S RMD Open; 2024 Jan; 10(1):. PubMed ID: 38233074 [TBL] [Abstract][Full Text] [Related]
11. The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors. Chang G; Chen Y; Liu Z; Wang Y; Ge W; Kang Y; Guo S J Immunol Res; 2022; 2022():3647817. PubMed ID: 35600045 [TBL] [Abstract][Full Text] [Related]
12. Enhanced Programmed Death 1 and Diminished Programmed Death Ligand 1 Up-Regulation Capacity of Post-Activated Lupus B Cells. Stefanski AL; Wiedemann A; Reiter K; Hiepe F; Lino AC; Dörner T Arthritis Rheumatol; 2019 Sep; 71(9):1539-1544. PubMed ID: 30919595 [TBL] [Abstract][Full Text] [Related]
13. Unbalanced expression of membrane-bound and soluble inducible costimulator and programmed cell death 1 in patients with myasthenia gravis. Yan X; Gu Y; Wang C; Sun S; Wang X; Tian J; Wang M; Ji X; Duan X; Gao H; Fang Q; Dong W; Zhang X; Xue Q Clin Immunol; 2019 Oct; 207():68-78. PubMed ID: 31374257 [TBL] [Abstract][Full Text] [Related]
14. PD-L1 Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A Front Immunol; 2018; 9():2241. PubMed ID: 30327652 [No Abstract] [Full Text] [Related]
15. [Expression and significance of PD-1 on CD4(+); and CD8(+); T cells from the peripheral blood of patients with systemic lupus erythematosus]. Wang Y; Xie C; Sun M; Chai J; Zhou Y; Chen Y; Tang J; Li B Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Sep; 29(9):962-5. PubMed ID: 24011159 [TBL] [Abstract][Full Text] [Related]
16. The immunoregulatory axis (programmed death-1/programmed death ligand-1) on CD4+ T cells in lupus nephritis: association with vitamin D and chemokine C-X-C motif ligand 12. Youssry S; Hussein A; Moaaz M Microbiol Immunol; 2021 Sep; 65(9):392-399. PubMed ID: 34081342 [TBL] [Abstract][Full Text] [Related]
17. Changes in the expression of T-cell factor-1 in follicular helper T cells reflect the condition of systemic lupus erythematosus patients. Zeng X; Zheng M; Liu T; Bahabayi A; Kang R; Xu Q; Alimu X; Lu S; Song Y; Liu C Int Immunopharmacol; 2022 Jul; 108():108877. PubMed ID: 35729844 [TBL] [Abstract][Full Text] [Related]
18. The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides. Grywalska E; Smarz-Widelska I; Krasowska-Zajac E; Korona-Glowniak I; Zaluska-Patel K; Mielnik M; Podgajna M; Malm A; Rolinski J; Zaluska W Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):133-143. PubMed ID: 28770269 [TBL] [Abstract][Full Text] [Related]
19. Increased interleukin 21 and follicular helper T-like cells and reduced interleukin 10+ B cells in patients with new-onset systemic lupus erythematosus. Wang L; Zhao P; Ma L; Shan Y; Jiang Z; Wang J; Jiang Y J Rheumatol; 2014 Sep; 41(9):1781-92. PubMed ID: 25028374 [TBL] [Abstract][Full Text] [Related]
20. Variable increased expression of program death-1 and program death-1 ligands on peripheral mononuclear cells is not impaired in patients with systemic lupus erythematosus. Liu MF; Weng CT; Weng MY J Biomed Biotechnol; 2009; 2009():406136. PubMed ID: 19759858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]